Atterocor Receives $16,000,000 Series A Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fd160b91-91e2-44a8-87f5-89a9b0f3ebc7&Preview=1 -
Date
8/6/2012 -
Company Name
Atterocor -
Mailing Address
820 Heatherway Ann Arbor, MI 48104 -
Company Description
Atterocor is an innovative company focused on the accelerated development of a treatment for adrenal cancer. Founded in 2012 and backed by top-tier life sciences investors, Atterocor is based in Ann Arbor, Michigan. -
Website
http://www.atterocor.com -
Transaction Type
Venture Equity -
Transaction Amount
$16,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Frazier Healthcare and 5AM Ventures led the round and proceeds from the financing will support Atterocor’s accelerated development of its lead program. -
M&A Terms
-
Venture Investor
Frazier Healthcare Ventures -
Venture Investor
5AM Ventures -
Venture Investor
Undisclosed
